RCG
IONS icon

Ruggie Capital Group’s Ionis Pharmaceuticals IONS Stock Holding History

Ruggie Capital Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50
Closed -$3K – 179
2019
Q2 		$3K Buy
+50
New +$3.53K 0.01% 201
2015
Q3 		– Sell
-20
Closed -$1K – 262
2015
Q2 		$1K Sell
20
-40
-67% -$2.54K ﹤0.01% 313
2015
Q1 		$4K Buy
+60
New +$4.07K ﹤0.01% 191

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ruggie Capital Group's IONS Position: Q3 2019 in Review

Ruggie Capital Group sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 50 shares — an estimated $3K sold.

Ruggie Capital Group first reported a position in IONS in Q1 2015 and held it in 3 quarters. The position peaked at $4K in Q1 2015. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

  • Ruggie Capital Group reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 50 Ionis Pharmaceuticals shares in Q3 2019, an estimated $3K.
  • Ruggie Capital Group first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Ruggie Capital Group's Ionis Pharmaceuticals position peaked at $4K in Q1 2015.
  • 369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Ruggie Capital Group's 13F filing for Q3 2019, filed 6 Nov 2019.